Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Catalent
Pharma
Novo Nordisk figures sales growth will slow slightly in 2025
Novo said Wednesday that it expects its sales growth in 2025 to be a bit milder compared to the heights of the prior year.
Fraiser Kansteiner
Feb 5, 2025 11:43am
Sales up 23% for Korean CDMO powerhouse Samsung Biologics
Jan 22, 2025 11:41am
2024's top biopharma M&A deals
Jan 13, 2025 3:00am
Nick Buschur takes over as CEO at blow-fill-seal CDMO Woodstock
Jan 7, 2025 3:00pm
Novo Holdings' $16.5B Calalent buyout to close in 'coming days'
Dec 16, 2024 11:51am
European officials approve Novo Holdings' planned Catalent buy
Dec 6, 2024 2:48pm
